NEUTRA CORP. (NTRR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US64129C3034
Price
0.00 USD
Market cap
583,579.82 USD
P/E (2026)
–
P/S (2026)
0.57
Dividend yield
0.00 %
Net margin
-0.68 %
Return on equity (ROE)
3.20 %
Return on assets (ROA)
-4.03 %
NEUTRA CORP. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 68,057.00 USD | 1.02 m USD |
| Gross profit | 63,233.00 USD | 656,763.00 USD |
| Operating income | -105,425.00 USD | 87,489.00 USD |
| Net income | -109,023.00 USD | -6,941.00 USD |
Full history since 2010, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About NEUTRA CORP.
Neutra Corp. researches, develops, and provides hemp-derived products in the nutraceutical space in the United States. The company sells hemp-derived products, including products containing delta-8-THC and other cannabinoids, CBD sports creams, and other products. Neutra Corp. was incorporated in 2011 and is based in Houston, Texas.
More stocks
- CLOUDASTRUCTURE, INC. (CSAI)
- Bright Mountain Media, Inc. (BMTM)
- Exousia Bio, Inc. (LMMY)
- Triller Group Inc. (ILLR)
- Digital Brand Media & Marketing Group, Inc. (DBMM)
- IIOT-OXYS, Inc. (ITOX)
- Mitesco, Inc. (MITI)
- Green Planet Bio Engineering Co. Ltd. (GPLB)
- Greenlane Holdings, Inc. (GNLN)
- Leslie's, Inc. (LESL)
- Target Group Inc. (CBDY)
- GOOD GAMING, INC. (GMER)
Not investment advice. All data without warranty, price as of 17.11.2026. Details in the risk notice.